These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


161 related items for PubMed ID: 8475358

  • 21. [Familial dysfibrinogenemia with abnormal nonomer aggregation. Paris III fibrinogen].
    Soria J, Soria C.
    Pathol Biol (Paris); 1974 Nov; 22 suppl():72-9. PubMed ID: 4620099
    [No Abstract] [Full Text] [Related]

  • 22. Episodes of increased fibronectin level observed in a patient suffering from recurrent thrombosis related to congenital hypodysfibrinogenaemia (fibrinogen Malmoe).
    Soria J, Soria C, Hedner U, Nilsson IM, Bergqvist D, Samama M.
    Br J Haematol; 1985 Dec; 61(4):727-38. PubMed ID: 4084461
    [Abstract] [Full Text] [Related]

  • 23. Fibrinogen Troyes--fibrinogen Metz. Two new cases of congenital dysfibrinogenemia.
    Soria J, Soria C, Samama M, Poirot E, Kling C.
    Thromb Diath Haemorrh; 1972 Jul 31; 27(3):619-33. PubMed ID: 4662617
    [No Abstract] [Full Text] [Related]

  • 24. Acquired dysfibrinogenemia caused by monoclonal production of immunoglobulin lambda light chain.
    Dear A, Brennan SO, Sheat MJ, Faed JM, George PM.
    Haematologica; 2007 Nov 31; 92(11):e111-7. PubMed ID: 18024387
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Acquired heparin-like anticoagulants: a second case in metastatic breast carcinoma and literature review.
    Hill GR, Hickton CM, Brennan SO, Atkinson CH, Heaton DC.
    Clin Lab Haematol; 1996 Dec 31; 18(4):291-5. PubMed ID: 9054706
    [Abstract] [Full Text] [Related]

  • 28. Laboratory testing for fibrinogen abnormalities.
    Verhovsek M, Moffat KA, Hayward CP.
    Am J Hematol; 2008 Dec 31; 83(12):928-31. PubMed ID: 18951466
    [Abstract] [Full Text] [Related]

  • 29. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women.
    Bombeli T, Raddatz-Mueller P, Fehr J.
    Am J Obstet Gynecol; 2001 Feb 31; 184(3):382-9. PubMed ID: 11228491
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Inhibition of thrombin generation in plasma by fibrin formation (Antithrombin I).
    de Bosch NB, Mosesson MW, Ruiz-Sáez A, Echenagucia M, Rodriguez-Lemoin A.
    Thromb Haemost; 2002 Aug 31; 88(2):253-8. PubMed ID: 12195697
    [Abstract] [Full Text] [Related]

  • 32. Report of three cases of circulating heparin-like anticoagulants.
    Llamas P, Outeiriño J, Espinoza J, Santos AB, Román A, Tomás JF.
    Am J Hematol; 2001 Aug 31; 67(4):256-8. PubMed ID: 11443639
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Change of viscoelastic property and morphology of fibrin affected by antithrombin III and heparin: QCM-Z and AFM study.
    Jung H, Tae G, Kim YH, Johannsmann D.
    Colloids Surf B Biointerfaces; 2009 Jan 01; 68(1):111-9. PubMed ID: 19004623
    [Abstract] [Full Text] [Related]

  • 35. Fibrinogen Denver: a dysfibrinogenemia associated with an abnormal Reptilase time and significant bleeding.
    Walter S, Stabler S, Lefkowitz JB.
    Haemophilia; 2006 Jul 01; 12(4):393-7. PubMed ID: 16834739
    [Abstract] [Full Text] [Related]

  • 36. Fibrinogen Matsumoto V: a variant with Aalpha19 Arg-->Gly (AGG-->GGG). Comparison between fibrin polymerization stimulated by thrombin or reptilase and fibrin monomer polymerization.
    Tanaka H, Terasawa F, Ito T, Tokunaga S, Ishida F, Kitano K, Kiyosawa K, Okumura N.
    Thromb Haemost; 2001 Jan 01; 85(1):108-13. PubMed ID: 11204560
    [Abstract] [Full Text] [Related]

  • 37. Fibrinogen Bastia (gamma 318 Asp-->Tyr) a novel abnormal fibrinogen characterized by defective fibrin polymerization.
    Lounes KC, Soria C, Valognes A, Turchini MF, Soria J, Koopman J.
    Thromb Haemost; 1999 Dec 01; 82(6):1639-43. PubMed ID: 10613648
    [Abstract] [Full Text] [Related]

  • 38. Inefficacy of fresh frozen plasma in the treatment of L-asparaginase-induced coagulation factor deficiencies during ALL induction therapy.
    Nowak-Göttl U, Rath B, Binder M, Hassel JU, Wolff J, Husemann S, Ritter J.
    Haematologica; 1995 Dec 01; 80(5):451-3. PubMed ID: 8566890
    [Abstract] [Full Text] [Related]

  • 39. A novel fibrinogen Bbeta chain frameshift mutation in a patient with severe congenital hypofibrinogenaemia.
    Xu X, Wu J, Zhai Z, Zhou R, Wang X, Wang H, Ding K, Sun Z, Ni H.
    Thromb Haemost; 2006 Jun 01; 95(6):931-5. PubMed ID: 16732370
    [Abstract] [Full Text] [Related]

  • 40. [Coagulation disorders without hemorrhagic diathesis due to delayed aggregration of fibrin molecules].
    von Felten A, Duckert F, Frick P.
    Schweiz Med Wochenschr; 1965 Oct 23; 95(43):1453-6. PubMed ID: 5880932
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.